Angelos M. Stergiou - Dec 2, 2021 Form 4 Insider Report for SELLAS Life Sciences Group, Inc. (SLS)

Role
President and CEO, Director
Signature
/s/ Angelos M. Stergiou
Stock symbol
SLS
Transactions as of
Dec 2, 2021
Transactions value $
-$13,252
Form type
4
Date filed
12/3/2021, 04:15 PM
Previous filing
Dec 3, 2021
Next filing
Feb 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLS Common Stock Sale -$13.3K -2.12K -1.72% $6.25 121K Dec 2, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2 The price reflects the weighted average sale price of the shares of common stock sold. These shares of common stock were sold in multiple transactions at prices ranging from $6.25 to $6.27, inclusive, per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock sold at each price.

Remarks:

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.